Cargando…

Management of Advanced Invasive Melanoma: New Strategies

The incidence of cutaneous melanoma (CM) is increasing. CM is defined as melanoma in situ when limited within the epidermis and invasive when atypical melanocytes progressively invade the dermis. Treatment of CM is challenging. On one hand, melanoma in situ does not require further treatment except...

Descripción completa

Detalles Bibliográficos
Autores principales: Villani, Alessia, Scalvenzi, Massimiliano, Micali, Giuseppe, Lacarrubba, Francesco, Fornaro, Luigi, Martora, Fabrizio, Potestio, Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329960/
https://www.ncbi.nlm.nih.gov/pubmed/37306810
http://dx.doi.org/10.1007/s12325-023-02555-5
_version_ 1785070128335945728
author Villani, Alessia
Scalvenzi, Massimiliano
Micali, Giuseppe
Lacarrubba, Francesco
Fornaro, Luigi
Martora, Fabrizio
Potestio, Luca
author_facet Villani, Alessia
Scalvenzi, Massimiliano
Micali, Giuseppe
Lacarrubba, Francesco
Fornaro, Luigi
Martora, Fabrizio
Potestio, Luca
author_sort Villani, Alessia
collection PubMed
description The incidence of cutaneous melanoma (CM) is increasing. CM is defined as melanoma in situ when limited within the epidermis and invasive when atypical melanocytes progressively invade the dermis. Treatment of CM is challenging. On one hand, melanoma in situ does not require further treatment except for a limited secondary excision with reduced margins to minimize the risk of local recurrences; on the other, invasive melanoma requires a personalized approach based on tumor staging. Consequently, an association of surgical and medical treatments is often necessary for invasive forms of the disease. In this scenario, new knowledge on melanoma pathogenesis has led to the development of safe and effective treatments, and several drugs are currently under investigation. However, extensive knowledge is required to offer patients a tailored-tail approach. The aim of our article was to review current literature to provide an overview of treatment options for invasive melanoma, highlighting strategical approaches that can be used in patients with these forms of disease.
format Online
Article
Text
id pubmed-10329960
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-103299602023-07-11 Management of Advanced Invasive Melanoma: New Strategies Villani, Alessia Scalvenzi, Massimiliano Micali, Giuseppe Lacarrubba, Francesco Fornaro, Luigi Martora, Fabrizio Potestio, Luca Adv Ther Review The incidence of cutaneous melanoma (CM) is increasing. CM is defined as melanoma in situ when limited within the epidermis and invasive when atypical melanocytes progressively invade the dermis. Treatment of CM is challenging. On one hand, melanoma in situ does not require further treatment except for a limited secondary excision with reduced margins to minimize the risk of local recurrences; on the other, invasive melanoma requires a personalized approach based on tumor staging. Consequently, an association of surgical and medical treatments is often necessary for invasive forms of the disease. In this scenario, new knowledge on melanoma pathogenesis has led to the development of safe and effective treatments, and several drugs are currently under investigation. However, extensive knowledge is required to offer patients a tailored-tail approach. The aim of our article was to review current literature to provide an overview of treatment options for invasive melanoma, highlighting strategical approaches that can be used in patients with these forms of disease. Springer Healthcare 2023-06-12 2023 /pmc/articles/PMC10329960/ /pubmed/37306810 http://dx.doi.org/10.1007/s12325-023-02555-5 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Review
Villani, Alessia
Scalvenzi, Massimiliano
Micali, Giuseppe
Lacarrubba, Francesco
Fornaro, Luigi
Martora, Fabrizio
Potestio, Luca
Management of Advanced Invasive Melanoma: New Strategies
title Management of Advanced Invasive Melanoma: New Strategies
title_full Management of Advanced Invasive Melanoma: New Strategies
title_fullStr Management of Advanced Invasive Melanoma: New Strategies
title_full_unstemmed Management of Advanced Invasive Melanoma: New Strategies
title_short Management of Advanced Invasive Melanoma: New Strategies
title_sort management of advanced invasive melanoma: new strategies
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329960/
https://www.ncbi.nlm.nih.gov/pubmed/37306810
http://dx.doi.org/10.1007/s12325-023-02555-5
work_keys_str_mv AT villanialessia managementofadvancedinvasivemelanomanewstrategies
AT scalvenzimassimiliano managementofadvancedinvasivemelanomanewstrategies
AT micaligiuseppe managementofadvancedinvasivemelanomanewstrategies
AT lacarrubbafrancesco managementofadvancedinvasivemelanomanewstrategies
AT fornaroluigi managementofadvancedinvasivemelanomanewstrategies
AT martorafabrizio managementofadvancedinvasivemelanomanewstrategies
AT potestioluca managementofadvancedinvasivemelanomanewstrategies